IRCT20210519051345N35招募中Unknown
Bioequivalence study of Tolterodine 2 mg tablet compared with innovator product
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- Male
入选标准
- •General Health (in terms of Liver, Heart and Kidney)
- •Age (18-59 years)
排除标准
- •History of cardiovascular disease, liver and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
尚未招募
不适用
Comparative in vivo evaluation of 2 Loratadine 10 mg Tablet formulations.IRCT20180620040164N41Karen Pharma and Food Supplement Co.24
已完成
2 期
Compare the effect of Tetoltoredine and solifenacin in treatment of over active bladder symptoms.stress incontinance.stress incontinanceIRCT2016101727998N3Vice Chancellor for Research, Tehran University of Medical Sciences100
已完成
3 期
The effect of Terazosin and Tolterodine in the treatment of double J stent-related urinary symptomsIRCT20160924029935N2Mashhad University of Medical Sciences80
尚未招募
不适用
Comparative in vivo evaluation of 2 Desloratadine 5 mg Tablet formulations.IRCT20180620040164N40Darou darman Pars Co.24
尚未招募
Unknown
Comparative in vivo evaluation of 2 Desloratadine 5 mg Tablet formulations.IRCT20180620040164N60Actover Pharmaceutical Co.24